Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide, an FDA-approved weight loss medication, functions as a glucagon-like peptide-1 (GLP-1) analogue, aiding in weight management by stimulating insulin release and slowing stomach emptying
This is why peptides are shipped in vials that are often amber or are packaged in light-blocking containers
Each production lot is independently characterized using high-performance liquid chromatography (HPLC) and liquid chromatographymass spectrometry (LCMS) protocols
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) New England Journal of Medicine 389(24) 2023PMID: 37952131 NEJM 5 U.S
The mechanism has been suggested to involve inhibition of cardiac intracellular signaling pathways (Ca 2+ /calmodulin-dependent protein kinase II and protein kinase C) due to saxagliptin-mediated inhibition DPP-9 (136)
